Sotera Health (NASDAQ:SHC) Shares Bought by Two Seas Capital LP

Two Seas Capital LP boosted its holdings in shares of Sotera Health (NASDAQ:SHC - Free Report) by 624.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,896,136 shares of the company's stock after purchasing an additional 2,496,136 shares during the quarter. Sotera Health makes up 3.1% of Two Seas Capital LP's holdings, making the stock its 8th largest position. Two Seas Capital LP owned about 1.02% of Sotera Health worth $39,619,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of SHC. Blue Trust Inc. increased its stake in Sotera Health by 164.3% during the 4th quarter. Blue Trust Inc. now owns 1,834 shares of the company's stock worth $25,000 after buying an additional 1,140 shares in the last quarter. Quarry LP acquired a new stake in shares of Sotera Health in the fourth quarter worth approximately $28,000. Tower Research Capital LLC TRC increased its position in shares of Sotera Health by 37.8% during the fourth quarter. Tower Research Capital LLC TRC now owns 5,975 shares of the company's stock worth $82,000 after purchasing an additional 1,640 shares in the last quarter. Sterling Capital Management LLC raised its stake in Sotera Health by 58.5% in the 4th quarter. Sterling Capital Management LLC now owns 9,029 shares of the company's stock valued at $124,000 after purchasing an additional 3,331 shares during the last quarter. Finally, PNC Financial Services Group Inc. raised its stake in Sotera Health by 39.4% in the 4th quarter. PNC Financial Services Group Inc. now owns 9,302 shares of the company's stock valued at $127,000 after purchasing an additional 2,627 shares during the last quarter. 91.03% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

SHC has been the subject of a number of research reports. The Goldman Sachs Group raised shares of Sotera Health from a "neutral" rating to a "buy" rating and upped their target price for the stock from $14.00 to $17.00 in a report on Monday, May 5th. Barclays dropped their price objective on shares of Sotera Health from $16.00 to $12.00 and set an "overweight" rating for the company in a research note on Thursday, April 10th. Finally, Piper Sandler decreased their target price on shares of Sotera Health from $15.00 to $13.00 and set a "neutral" rating on the stock in a research note on Wednesday, April 23rd. One research analyst has rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $15.80.

Sotera Health Stock Performance

Shares of SHC opened at $12.82 on Wednesday. Sotera Health has a 1 year low of $9.53 and a 1 year high of $17.08. The stock has a market capitalization of $3.64 billion, a PE ratio of 51.28 and a beta of 1.88. The company has a debt-to-equity ratio of 4.91, a quick ratio of 2.61 and a current ratio of 2.88. The stock has a 50-day simple moving average of $11.63 and a 200-day simple moving average of $12.80.

Sotera Health (NASDAQ:SHC - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The company reported $0.14 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.12 by $0.02. Sotera Health had a net margin of 6.31% and a return on equity of 42.27%. The company had revenue of $254.52 million during the quarter, compared to the consensus estimate of $245.56 million. During the same quarter in the previous year, the firm earned $0.13 earnings per share. The firm's quarterly revenue was up 2.6% on a year-over-year basis. On average, analysts predict that Sotera Health will post 0.61 earnings per share for the current fiscal year.

Sotera Health Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.

Want to see what other hedge funds are holding SHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sotera Health (NASDAQ:SHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.